These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7523265)

  • 1. Blood and plasma 5-hydroxytryptamine levels in patients with cirrhosis.
    Beaudry P; Hadengue A; Callebert J; Gaudin C; Soliman H; Moreau R; Launay JM; Lebrec D
    Hepatology; 1994 Oct; 20(4 Pt 1):800-3. PubMed ID: 7523265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension.
    La Mura V; Reverter JC; Flores-Arroyo A; Raffa S; Reverter E; Seijo S; Abraldes JG; Bosch J; García-Pagán JC
    Gut; 2011 Aug; 60(8):1133-8. PubMed ID: 21427197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic effects of glucagon in portal hypertension.
    Silva G; Navasa M; Bosch J; Chesta J; Pilar Pizcueta M; Casamitjana R; Rivera F; Rodés J
    Hepatology; 1990 Apr; 11(4):668-73. PubMed ID: 2328958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of sex hormone levels in patients with hepatitis B virus-related postnecrotic cirrhosis: relationship to the severity of portal hypertension.
    Wang YJ; Lee SD; Lin HC; Hsia HC; Lee FY; Tsai YT; Lo KJ
    J Hepatol; 1993 Apr; 18(1):101-5. PubMed ID: 8340601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient elastography for diagnosis of portal hypertension in liver cirrhosis: is there still a role for hepatic venous pressure gradient measurement?
    Lim JK; Groszmann RJ
    Hepatology; 2007 May; 45(5):1087-90. PubMed ID: 17464984
    [No Abstract]   [Full Text] [Related]  

  • 6. TIMP-1 in patients with cirrhosis: relation to liver dysfunction, portal hypertension, and hemodynamic changes.
    Busk TM; Bendtsen F; Nielsen HJ; Jensen V; Brünner N; Møller S
    Scand J Gastroenterol; 2014 Sep; 49(9):1103-10. PubMed ID: 25048331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of soluble vascular cell adhesion molecule are related to hyperdynamic circulation in patients with liver cirrhosis.
    Lo Iacono O; Rincón D; Hernando A; Ripoll C; Catalina MV; Salcedo M; Clemente G; Gomez J; Nuñez O; Matilla A; Bañares R
    Liver Int; 2008 Sep; 28(8):1129-35. PubMed ID: 18482273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased urotensin II plasma levels in patients with cirrhosis and portal hypertension.
    Heller J; Schepke M; Neef M; Woitas R; Rabe C; Sauerbruch T
    J Hepatol; 2002 Dec; 37(6):767-72. PubMed ID: 12445417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma and platelet serotonin levels in patients with liver cirrhosis.
    Culafic DM; Mirkovic DS; Vukcevic MD; Rudic JS
    World J Gastroenterol; 2007 Nov; 13(43):5750-3. PubMed ID: 17963303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic effects of nifedipine on hepatic venous pressure gradient in patients with portal hypertension.
    Straumann A; Gyr K; Kiowski W; Bruendler H; Stalder GA
    Hepatogastroenterology; 1986 Jun; 33(3):101-4. PubMed ID: 3744280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of 833 times measured hepatic venous pressure gradient].
    Zhang MY; Wang GC; Huang GJ; Feng H; Wang LF; Zhang JY; Shi YJ; Zhang CQ
    Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):266-270. PubMed ID: 29996337
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of viral suppression on hepatic venous pressure gradient in hepatitis C with cirrhosis and portal hypertension.
    Afdhal N; Everson GT; Calleja JL; McCaughan GW; Bosch J; Brainard DM; McHutchison JG; De-Oertel S; An D; Charlton M; Reddy KR; Asselah T; Gane E; Curry MP; Forns X
    J Viral Hepat; 2017 Oct; 24(10):823-831. PubMed ID: 28295923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Measurement of hepatic venous pressure gradient in liver cirrhosis: relationship with the status of cirrhosis, varices, and ascites in Korea].
    Kim MY; Baik SK; Suk KT; Yea CJ; Lee IY; Kim JW; Cha SH; Kim YJ; Um SH; Han KH
    Korean J Hepatol; 2008 Jun; 14(2):150-8. PubMed ID: 18617762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble CD163, a marker of Kupffer cell activation, is related to portal hypertension in patients with liver cirrhosis.
    Grønbaek H; Sandahl TD; Mortensen C; Vilstrup H; Møller HJ; Møller S
    Aliment Pharmacol Ther; 2012 Jul; 36(2):173-80. PubMed ID: 22591184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Damping index of Doppler hepatic vein waveform to assess the severity of portal hypertension and response to propranolol in liver cirrhosis: a prospective nonrandomized study.
    Kim MY; Baik SK; Park DH; Lim DW; Kim JW; Kim HS; Kwon SO; Kim YJ; Chang SJ; Lee SS
    Liver Int; 2007 Oct; 27(8):1103-10. PubMed ID: 17845539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrahepatic heterogeneity of hepatic venous pressure gradient in human cirrhosis again.
    Keiding S; Vilstrup H
    Scand J Gastroenterol; 2002 Nov; 37(11):1344. PubMed ID: 12465737
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of hepatic venous pressure gradient and endoscopic grading of esophageal varices.
    Lee E; Kim YJ; Goo DE; Yang SB; Kim HJ; Jang JY; Jeong SW
    World J Gastroenterol; 2016 Mar; 22(11):3212-9. PubMed ID: 27003998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of Doppler ultrasonography and hepatic venous pressure gradient in assessing portal hypertension in liver cirrhosis].
    Jeong PH; Baik SK; Choi YJ; Park DH; Kim MY; Kim HS; Lee DK; Kwon SO; Kim YJ; Park JW; Kim ND
    Taehan Kan Hakhoe Chi; 2002 Sep; 8(3):264-70. PubMed ID: 12499783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships between the severity of cirrhosis and haemodynamic values in patients with cirrhosis.
    Meng HC; Lin HC; Tsai YT; Lee FY; Liao DM; Hsia HC; Lin WJ; Chang TT; Lay CS; Wang SS
    J Gastroenterol Hepatol; 1994; 9(2):148-53. PubMed ID: 8003648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteopontin: A non-invasive parameter of portal hypertension and prognostic marker of cirrhosis.
    Bruha R; Jachymova M; Petrtyl J; Dvorak K; Lenicek M; Urbanek P; Svestka T; Vitek L
    World J Gastroenterol; 2016 Mar; 22(12):3441-50. PubMed ID: 27022226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.